Epstein-Barr	B-protein
virus-transforming	I-protein
protein	I-protein
latent	B-protein
infection	I-protein
membrane	I-protein
protein	I-protein
1	I-protein
activates	O
transcription	B-protein
factor	I-protein
NF-kappaB	I-protein
through	O
a	O
pathway	O
that	O
includes	O
the	O
NF-kappaB-inducing	B-protein
kinase	I-protein
and	O
the	O
IkappaB	B-protein
kinases	I-protein
IKKalpha	B-protein
and	O
IKKbeta	B-protein
.	O

The	O
Epstein-Barr	B-protein
virus	I-protein
oncoprotein	I-protein
latent	B-protein
infection	I-protein
membrane	I-protein
protein	I-protein
1	I-protein
(	O
LMP1	B-protein
)	O
is	O
a	O
constitutively	O
aggregated	O
pseudo-tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
(	O
TNFR	B-protein
)	O
that	O
activates	O
transcription	B-protein
factor	I-protein
NF-kappaB	I-protein
through	O
two	O
sites	O
in	O
its	O
C-terminal	B-protein
cytoplasmic	I-protein
domain	I-protein
.	O

One	O
site	O
is	O
similar	O
to	O
activated	O
TNFRII	B-protein
in	O
associating	O
with	O
TNFR-associated	B-protein
factors	I-protein
TRAF1	B-protein
and	O
TRAF2	B-protein
,	O
and	O
the	O
second	O
site	O
is	O
similar	O
to	O
TNFRI	B-protein
in	O
associating	O
with	O
the	O
TNFRI	B-protein
death	I-protein
domain	I-protein
interacting	I-protein
protein	I-protein
TRADD	B-protein
.	O

TNFRI	B-protein
has	O
been	O
recently	O
shown	O
to	O
activate	O
NF-kappaB	B-protein
through	O
association	O
with	O
TRADD	B-protein
,	O
RIP	B-protein
,	O
and	O
TRAF2	B-protein
;	O
activation	O
of	O
the	O
NF-kappaB-inducing	B-protein
kinase	I-protein
(	O
NIK	B-protein
)	O
;	O
activation	O
of	O
the	O
IkappaB	B-protein
alpha	I-protein
kinases	I-protein
(	O
IKKalpha	B-protein
and	O
IKKbeta	B-protein
)	O
;	O
and	O
phosphorylation	O
of	O
IkappaB	B-protein
alpha	I-protein
.	O

IkappaB	B-protein
alpha	I-protein
phosphorylation	O
on	O
Ser-32	O
and	O
Ser-36	O
is	O
followed	O
by	O
its	O
degradation	O
and	O
NF-kappaB	B-protein
activation	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
NF-kappaB	B-protein
activation	O
by	O
LMP1	B-protein
or	O
by	O
each	O
of	O
its	O
effector	B-protein
sites	I-protein
is	O
mediated	O
by	O
a	O
pathway	O
that	O
includes	O
NIK	B-protein
,	O
IKKalpha	B-protein
,	O
and	O
IKKbeta	B-protein
.	O

Dominant	B-protein
negative	I-protein
mutants	I-protein
of	O
NIK	B-protein
,	O
IKKalpha	B-protein
,	O
or	O
IKKbeta	B-protein
substantially	O
inhibited	O
NF-kappaB	B-protein
activation	O
by	O
LMP1	B-protein
or	O
by	O
each	O
of	O
its	O
effector	B-protein
sites	I-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

10106-10111	NULL
,	NULL
August	NULL
1998	NULL
Medical	NULL
Sciences	NULL
Epstein-Barr	NULL
virus-transforming	NULL
protein	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-B	NULL
through	NULL
a	NULL
pathway	NULL
that	NULL
includes	NULL
the	NULL
NF-B-inducing	NULL
kinase	NULL
and	NULL
the	NULL
IxB	NULL
kinases	NULL
IKKa	NULL
and	NULL
IKK	NULL
BAKARY	NULL
S.	NULL
SYyLLaA*	NULL
,	NULL
SIU	NULL
CHun	NULL
Hunc*	NULL
,	NULL
Davin	NULL
M.	NULL
Davipson*	NULL
,	NULL
EUpoxIa	NULL
HaTzIvASsILIOU*	NULL
,	NULL
NIKOLAI	NULL
L.	NULL
Davi	NULL
WarracHt	NULL
,	NULL
THomas	NULL
D	NULL
.	NULL

GimmorRE	NULL
?	NULL

,	NULL
EpuioTTt	NULL
KiErFr*§	NULL
,	NULL
anp	NULL
GEorar	NULL
MostaLOs*	NULL
*Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
and	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
and	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
181	NULL
Longwood	NULL
Avenue	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
,	NULL
02115	NULL
;	NULL
*Department	NULL
of	NULL
Membrane	NULL
Research	NULL
and	NULL
Biophysics	NULL
,	NULL
The	NULL
Weizmann	NULL
Institute	NULL
of	NULL
Science	NULL
,	NULL
76100	NULL
Rehovot	NULL
,	NULL
Israel	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biology	NULL
,	NULL
Boston	NULL
University	NULL
,	NULL
5	NULL
Cummington	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
Contributed	NULL
by	NULL
Elloitt	NULL
Kieff	NULL
,	NULL
June	NULL
9	NULL
,	NULL
1998	NULL
ABSTRACT	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
oncoprotein	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
a	NULL
constitutively	NULL
aggregated	NULL
pseudo-tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
that	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-B	NULL
through	NULL
two	NULL
sites	NULL
in	NULL
its	NULL
C-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

One	NULL
site	NULL
is	NULL
similar	NULL
to	NULL
activated	NULL
TNFRII	NULL
in	NULL
associating	NULL
with	NULL
TNFR-associated	NULL
factors	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
,	NULL
and	NULL
the	NULL
second	NULL
site	NULL
is	NULL
similar	NULL
to	NULL
TNFRI	NULL
in	NULL
associating	NULL
with	NULL
the	NULL
TNFRI	NULL
death	NULL
domain	NULL
interacting	NULL
protein	NULL
TRADD	NULL
.	NULL

TNFRI	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
activate	NULL
NF-xB	NULL
through	NULL
association	NULL
with	NULL
TRADD	NULL
,	NULL
RIP	NULL
,	NULL
and	NULL
TRAF2	NULL
;	NULL
activation	NULL
of	NULL
the	NULL
NF-B-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
;	NULL
activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinases	NULL
(	NULL
IKKa	NULL
and	NULL
IKK	NULL
)	NULL
;	NULL
and	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
.	NULL

IxBa	NULL
phosphorylation	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
is	NULL
followed	NULL
by	NULL
its	NULL
degradation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
activation	NULL
by	NULL
LMP1	NULL
or	NULL
by	NULL
each	NULL
of	NULL
its	NULL
effector	NULL
sites	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
pathway	NULL
that	NULL
includes	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKK	NULL
3	NULL
.	NULL

Dominant	NULL
negative	NULL
mutants	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKK	NULL
3	NULL
substantially	NULL
inhibited	NULL
activation	NULL
by	NULL
LMP1	NULL
or	NULL
by	NULL
each	NULL
of	NULL
its	NULL
effector	NULL
sites	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
a	NULL
key	NULL
effector	NULL
of	NULL
EBV-mediated	NULL
effects	NULL
on	NULL
cell	NULL
growth	NULL
.	NULL

Genetic	NULL
analyses	NULL
with	NULL
EBV	NULL
recombinants	NULL
indicate	NULL
that	NULL
LMP1	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
conversion	NULL
of	NULL
resting	NULL
human	NULL
B	NULL
lymphocytes	NULL
into	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
non-EBV-infected	NULL
Burkitt	NULL
's	NULL
tumor	NULL
lymphoblasts	NULL
,	NULL
LMP1	NULL
can	NULL
induce	NULL
most	NULL
of	NULL
the	NULL
phenotypic	NULL
changes	NULL
associated	NULL
with	NULL
EBV	NULL
transformation	NULL
of	NULL
resting	NULL
human	NULL
B	NULL
lymphocytes	NULL
including	NULL
induction	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
up-regulation	NULL
of	NULL
Bel-2	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

2-8	NULL
)	NULL
.	NULL

LMP1	NULL
can	NULL
also	NULL
transform	NULL
immortalized	NULL
rodent	NULL
fibroblast	NULL
cell	NULL
lines	NULL
to	NULL
loss	NULL
of	NULL
contact	NULL
inhibition	NULL
,	NULL
lower	NULL
serum	NULL
dependence	NULL
,	NULL
anchorage	NULL
inde-pendence	NULL
,	NULL
and	NULL
tumorigenicity	NULL
in	NULL
nude	NULL
mice	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

LMP1	NULL
is	NULL
likely	NULL
to	NULL
alter	NULL
cell	NULL
growth	NULL
by	NULL
mimicking	NULL
a	NULL
constitutively	NULL
activated	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
similar	NULL
to	NULL
TNFRII	NULL
and	NULL
TNFRI	NULL
,	NULL
CD40	NULL
,	NULL
or	NULL
CD30	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

LMP1	NULL
has	NULL
a	NULL
short	NULL
24-amino	NULL
acid	NULL
cytoplasmic	NULL
N	NULL
terminus	NULL
,	NULL
six	NULL
transmembrane	NULL
domains	NULL
connected	NULL
by	NULL
short	NULL
turns	NULL
,	NULL
and	NULL
a	NULL
200-amino	NULL
acid	NULL
cytoplasmic	NULL
C	NULL
terminus	NULL
(	NULL
CCT	NULL
)	NULL
(	NULL
ref	NULL
.	NULL

2	NULL
and	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
N	NULL
terminus	NULL
anchors	NULL
the	NULL
first	NULL
transmembrane	NULL
domain	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
any	NULL
specific	NULL
codon	NULL
does	NULL
not	NULL
ablate	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
mutated	NULL
EBV	NULL
recombinant	NULL
to	NULL
transform	NULL
B	NULL
lymphocytes	NULL
into	NULL
LCLs	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
transmembrane	NULL
domains	NULL
enable	NULL
LMP1	NULL
to	NULL
aggregate	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424/98/9510106-6	NULL
$	NULL
2.00/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

10106	NULL
Aggregation	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
is	NULL
essential	NULL
for	NULL
activity	NULL
because	NULL
EBV	NULL
recombinants	NULL
that	NULL
express	NULL
a	NULL
nonaggregating	NULL
mutant	NULL
LMP1	NULL
that	NULL
diffusely	NULL
distributes	NULL
in	NULL
the	NULL
plasma	NULL
membranes	NULL
are	NULL
unable	NULL
to	NULL
convert	NULL
B	NULL
lymphocytes	NULL
into	NULL
LCLs	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Another	NULL
nonaggregating	NULL
mutant	NULL
that	NULL
diffusely	NULL
distributes	NULL
in	NULL
all	NULL
cytoplasmic	NULL
membranes	NULL
does	NULL
not	NULL
induce	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
or	NULL
rodent	NULL
fibroblasts	NULL
or	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
2	NULL
,	NULL
4-6	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
LMP1	NULL
CCT	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
the	NULL
transformation	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
into	NULL
LCLs	NULL
(	NULL
17	NULL
)	NULL
.	NULL

An	NULL
EBV	NULL
recombinant	NULL
that	NULL
expresses	NULL
only	NULL
the	NULL
N	NULL
terminus	NULL
,	NULL
the	NULL
transmembrane	NULL
domains	NULL
,	NULL
and	NULL
the	NULL
first	NULL
45	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
CCT	NULL
can	NULL
initiate	NULL
B	NULL
cell	NULL
growth	NULL
transformation	NULL
and	NULL
some	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
can	NULL
grow	NULL
into	NULL
long-term	NULL
LCLs	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
first	NULL
45	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
CCT	NULL
include	NULL
a	NULL
site	NULL
that	NULL
can	NULL
bind	NULL
TNFR	NULL
-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
18	NULL
)	NULL
.	NULL

These	NULL
same	NULL
45	NULL
amino	NULL
acids	NULL
mediate	NULL
a	NULL
minor	NULL
component	NULL
of	NULL
the	NULL
LMP	NULL
NF-KB	NULL
activation	NULL
and	NULL
have	NULL
been	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
C-terminal	NULL
activation	NULL
region	NULL
1	NULL
(	NULL
CTAR1	NULL
)	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

A	NULL
27-codon	NULL
deletion	NULL
in	NULL
LMP1	NULL
that	NULL
includes	NULL
this	NULL
TRAF-binding	NULL
site	NULL
renders	NULL
EBV	NULL
recombinants	NULL
incompetent	NULL
for	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transfor-mation	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
is	NULL
a	NULL
key	NULL
transformation	NULL
effector	NULL
site	NULL
(	NULL
TES1	NULL
;	NULL
ref	NULL
.	NULL

19	NULL
)	NULL
.	NULL

A	NULL
second	NULL
transformation	NULL
effector	NULL
site	NULL
(	NULL
TES2	NULL
)	NULL
maps	NULL
to	NULL
the	NULL
last	NULL
few	NULL
residues	NULL
of	NULL
the	NULL
CCT	NULL
(	NULL
14	NULL
)	NULL
.	NULL

TES2	NULL
associates	NULL
with	NULL
the	NULL
TNFR1	NULL
death	NULL
domain	NULL
interacting	NULL
protein	NULL
TRADD	NULL
(	NULL
14	NULL
)	NULL
and	NULL
correlates	NULL
with	NULL
the	NULL
major	NULL
NF-	NULL
«	NULL
B-activating	NULL
domain	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
14	NULL
,	NULL
20	NULL
)	NULL
.	NULL

TES1	NULL
and	NULL
TES2	NULL
are	NULL
within	NULL
the	NULL
C-terminal	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
regions	NULL
1	NULL
and	NULL
2	NULL
(	NULL
CTAR1	NULL
and	NULL
CTAR2	NULL
)	NULL
that	NULL
mediate	NULL
30	NULL
%	NULL
and	NULL
70	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
to	NULL
TES1	NULL
mediates	NULL
NF-KB	NULL
activation	NULL
from	NULL
CTAR1	NULL
,	NULL
whereas	NULL
TRADD	NULL
binding	NULL
to	NULL
TES2	NULL
mediates	NULL
NF-KB	NULL
activation	NULL
from	NULL
CTAR2	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
genetic	NULL
linkage	NULL
of	NULL
LMP1	NULL
effector	NULL
sites	NULL
for	NULL
cell	NULL
growth	NULL
transformation	NULL
with	NULL
effector	NULL
sites	NULL
for	NULL
NF-kB	NULL
activation	NULL
and	NULL
the	NULL
key	NULL
role	NULL
of	NULL
NF-KB	NULL
in	NULL
lymphocyte	NULL
activation	NULL
(	NULL
21	NULL
)	NULL
are	NULL
compatible	NULL
with	NULL
the	NULL
working	NULL
hypotheses	NULL
that	NULL
TRAFs	NULL
and	NULL
TRADD	NULL
are	NULL
key	NULL
mediators	NULL
of	NULL
LMP1	NULL
effects	NULL
in	NULL
cell	NULL
growth	NULL
transformation	NULL
and	NULL
that	NULL
NF-KB	NULL
is	NULL
an	NULL
important	NULL
component	NULL
of	NULL
those	NULL
effects	NULL
.	NULL

Pursuant	NULL
to	NULL
the	NULL
linkage	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
with	NULL
LMP1	NULL
effects	NULL
on	NULL
B	NULL
lymphocyte	NULL
growth	NULL
,	NULL
we	NULL
now	NULL
further	NULL
investigate	NULL
the	NULL
molecular	NULL
mechanism	NULL
through	NULL
which	NULL
LMP1	NULL
mediates	NULL
NF-KB	NULL
activation	NULL
.	NULL

TNF	NULL
appears	NULL
to	NULL
induce	NULL
NF-KB	NULL
activation	NULL
through	NULL
a	NULL
Abbreviations	NULL
:	NULL
TNFR	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
;	NULL
TRAF	NULL
,	NULL
TNFR-associated	NULL
factor	NULL
;	NULL
TRADD	NULL
,	NULL
TNFR	NULL
1	NULL
death	NULL
domain	NULL
interacting	NULL
protein	NULL
;	NULL
NIK	NULL
,	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
;	NULL
IKK	NULL
,	NULL
1B	NULL
kinase	NULL
;	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
LMP1	NULL
,	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
;	NULL
LCL	NULL
,	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
;	NULL
CCT	NULL
,	NULL
cytoplasmic	NULL
C	NULL
terminus	NULL
;	NULL
CTAR	NULL
,	NULL
C-terminal	NULL
activation	NULL
region	NULL
;	NULL
TES	NULL
,	NULL
transformation	NULL
effector	NULL
site	NULL
;	NULL
EST	NULL
,	NULL
expressed	NULL
sequence	NULL
tag	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

e-mail	NULL
:	NULL
ekieff	NULL
@	NULL
rics.bwh.harvard.edu	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Sylla	NULL
et	NULL
al	NULL
.	NULL

Membrane	NULL
<	NULL
INIK	NULL
___	NULL
``	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Schematic	NULL
diagram	NULL
of	NULL
aggregated	NULL
LMP1	NULL
in	NULL
the	NULL
cell	NULL
plasma	NULL
membrane	NULL
.	NULL

TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
constitutively	NULL
associate	NULL
with	NULL
the	NULL
LMP1-proximal	NULL
NF-	NULL
«	NULL
B-activating	NULL
region	NULL
(	NULL
CTAR1	NULL
)	NULL
,	NULL
which	NULL
is	NULL
also	NULL
a	NULL
key	NULL
transformation	NULL
effector	NULL
site	NULL
(	NULL
TES1	NULL
)	NULL
.	NULL

TRADD	NULL
constitutively	NULL
associates	NULL
with	NULL
the	NULL
LMP1	NULL
distal	NULL
and	NULL
major	NULL
NF-	NULL
«	NULL
B-activating	NULL
domain	NULL
(	NULL
CTAR2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
second	NULL
transformation	NULL
effector	NULL
site	NULL
(	NULL
TES2	NULL
)	NULL
.	NULL

Aggregation	NULL
of	NULL
TRAF2	NULL
most	NULL
likely	NULL
activates	NULL
NIK	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
and	NULL
activates	NULL
IKKa	NULL
and	NULL
IKK	NULL
.	NULL

IKKa	NULL
and	NULL
IKK	NULL
then	NULL
phosphorylate	NULL
I	NULL
«	NULL
Ba	NULL
,	NULL
leading	NULL
to	NULL
its	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

kinase	NULL
cascade	NULL
with	NULL
two	NULL
key	NULL
elements	NULL
:	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
,	NULL
a	NULL
TRAFZ-associated	NULL
MAP3K	NULL
homologue	NULL
that	NULL
is	NULL
required	NULL
for	NULL
NF-KB	NULL
activation	NULL
by	NULL
TNFRs	NULL
and	NULL
interleukin	NULL
1	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
IKKa/	NULL
$	NULL
B	NULL
,	NULL
a	NULL
NIK	NULL
-associated	NULL
IxBa	NULL
kinase	NULL
complex	NULL
(	NULL
23-27	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
this	NULL
pathway	NULL
in	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
dominant-negative	NULL
mutants	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKKB	NULL
on	NULL
LMP1-induced	NULL
NF-kB	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Constructs	NULL
.	NULL

The	NULL
expression	NULL
constructs	NULL
of	NULL
wild-type	NULL
human	NULL
NIK	NULL
and	NULL
a	NULL
dominant	NULL
negative	NULL
``	NULL
inactive	NULL
``	NULL
mutant	NULL
of	NULL
NIK	NULL
with	NULL
Lys-429	NULL
and	NULL
Lys-430	NULL
mutated	NULL
to	NULL
Ala	NULL
(	NULL
NIK	NULL
KK429-430AA	NULL
)	NULL
have	NULL
been	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Full-length	NULL
LMP1	NULL
,	NULL
LMP1	NULL
lacking	NULL
the	NULL
membrane	NULL
distal	NULL
NF-	NULL
«	NULL
B-activating	NULL
domain	NULL
(	NULL
FLMPA232-386	NULL
;	NULL
referred	NULL
to	NULL
as	NULL
F-LMPCTAR1	NULL
)	NULL
,	NULL
or	NULL
LMP1	NULL
lacking	NULL
the	NULL
membrane-proximal	NULL
NF-	NULL
«	NULL
B-activating	NULL
domain	NULL
(	NULL
FLMPA188-351	NULL
;	NULL
referred	NULL
to	NULL
as	NULL
F-LMPCTAR2	NULL
)	NULL
subcloned	NULL
in	NULL
pCDNA3	NULL
were	NULL
obtained	NULL
from	NULL
W.	NULL
Miller	NULL
(	NULL
28	NULL
)	NULL
.	NULL

pSGS-F-LMP1	NULL
is	NULL
described	NULL
elsewhere	NULL
(	NULL
13	NULL
)	NULL
.	NULL

F	NULL
designates	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
FLAG	NULL
epitope	NULL
in	NULL
the	NULL
N	NULL
terminus	NULL
.	NULL

Human	NULL
IxBa	NULL
and	NULL
IxBa	NULL
mutants	NULL
were	NULL
subcloned	NULL
into	NULL
pGEM4	NULL
.	NULL

The	NULL
Myc-tagged	NULL
wild-type	NULL
IKKa	NULL
and	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
IKKaKA44A	NULL
(	NULL
M-IKKa	NULL
and	NULL
M-IKKaK44A	NULL
;	NULL
ref	NULL
.	NULL

23	NULL
)	NULL
subcloned	NULL
in	NULL
pRKS	NULL
were	NULL
obtained	NULL
from	NULL
M.	NULL
Rothe	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

Cloning	NULL
of	NULL
IKK	NULL
.	NULL

The	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
DNA	NULL
database	NULL
was	NULL
screened	NULL
for	NULL
sequences	NULL
similar	NULL
to	NULL
the	NULL
IKKa	NULL
sequence	NULL
(	NULL
23	NULL
,	NULL
25	NULL
)	NULL
.	NULL

An	NULL
expressed	NULL
sequence	NULL
tag	NULL
(	NULL
EST	NULL
;	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

W68756	NULL
)	NULL
was	NULL
identified	NULL
.	NULL

The	NULL
EST	NULL
sequence	NULL
aligned	NULL
with	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
624-658	NULL
)	NULL
of	NULL
IKKa	NULL
.	NULL

From	NULL
this	NULL
EST	NULL
sequence	NULL
,	NULL
gene-specific	NULL
primers	NULL
were	NULL
designed	NULL
and	NULL
used	NULL
to	NULL
amplify	NULL
by	NULL
PCR	NULL
the	NULL
cDNA	NULL
(	NULL
s	NULL
)	NULL
containing	NULL
upstream	NULL
sequences	NULL
from	NULL
a	NULL
human	NULL
B	NULL
lymphoma	NULL
cDNA	NULL
library	NULL
(	NULL
Advantage	NULL
cDNA	NULL
polymerase	NULL
mix-ture	NULL
,	NULL
CLONTECH	NULL
)	NULL
.	NULL

Two	NULL
cDNA	NULL
products	NULL
whose	NULL
sequences	NULL
were	NULL
similar	NULL
to	NULL
IKKa	NULL
were	NULL
fused	NULL
with	NULL
the	NULL
downstream	NULL
sequence	NULL
in	NULL
the	NULL
EST	NULL
clone	NULL
(	NULL
purchased	NULL
from	NULL
Genome	NULL
Systems	NULL
)	NULL
to	NULL
obtain	NULL
pIKK	NULL
$	NULL
B-1	NULL
and	NULL
pIKKB-2	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
pIKKB-1	NULL
and	NULL
pIKKB-2	NULL
were	NULL
later	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
corre-	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
10107	NULL
sponding	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IKK	NULL
sequence	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

AFO29684	NULL
)	NULL
(	NULL
24	NULL
)	NULL
,	NULL
except	NULL
that	NULL
pIKKB-1	NULL
lacks	NULL
the	NULL
N-terminal	NULL
9	NULL
codons	NULL
of	NULL
IKKB	NULL
and	NULL
pIKKB-2	NULL
lacks	NULL
the	NULL
N-terminal	NULL
34	NULL
codons	NULL
,	NULL
the	NULL
latter	NULL
deletion	NULL
including	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
predicted	NULL
kinase	NULL
domain	NULL
.	NULL

In	NULL
addi-tion	NULL
,	NULL
pIKKB-2	NULL
contained	NULL
the	NULL
transition	NULL
A	NULL
-	NULL
>	NULL
G	NULL
at	NULL
the	NULL
second	NULL
base	NULL
of	NULL
the	NULL
codon	NULL
242	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
published	NULL
IKKB	NULL
sequence	NULL
.	NULL

The	NULL
resulting	NULL
IKKB	NULL
sequences	NULL
from	NULL
pIKKB-1	NULL
and	NULL
pIKKB-2	NULL
were	NULL
then	NULL
fused	NULL
in-frame	NULL
downstream	NULL
of	NULL
the	NULL
FLAG-epitope-encoding	NULL
sequence	NULL
in	NULL
pCDNA3	NULL
to	NULL
create	NULL
pCDNA3-FLAG-IKKBA9	NULL
and	NULL
pCDN3-FLAG-IKKBA34	NULL
,	NULL
respectively	NULL
.	NULL

Transfections	NULL
and	NULL
Reporter	NULL
Gene	NULL
Assays	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
introduced	NULL
into	NULL
human	NULL
embryonic	NULL
kidney	NULL
293	NULL
cells	NULL
by	NULL
elec-troporation	NULL
(	NULL
6	NULL
)	NULL
or	NULL
using	NULL
the	NULL
``	NULL
superfect	NULL
``	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Chats-worth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
24	NULL
h	NULL
before	NULL
transfection	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
were	NULL
seeded	NULL
in	NULL
six-well	NULL
plates	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
D10	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Plasmid	NULL
DNAs	NULL
were	NULL
mixed	NULL
with	NULL
10	NULL
ul	NULL
of	NULL
superfect	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
DMEM	NULL
without	NULL
serum	NULL
.	NULL

After	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
transfection	NULL
mixture	NULL
was	NULL
dripped	NULL
to	NULL
the	NULL
wells	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
changed	NULL
to	NULL
D10	NULL
after	NULL
4	NULL
h.	NULL
All	NULL
transfections	NULL
included	NULL
an	NULL
expression	NULL
plasmid	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
containing	NULL
three	NULL
NF-KB	NULL
sites	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
ug	NULL
of	NULL
a	NULL
control	NULL
B-galactosidase	NULL
expression	NULL
construct	NULL
(	NULL
pGK	NULL
gal	NULL
)	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Sixteen	NULL
to	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
luciferase	NULL
and	NULL
B-gal	NULL
activities	NULL
,	NULL
and	NULL
protein	NULL
expression	NULL
level	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Immune	NULL
Precipitation	NULL
and	NULL
Western	NULL
Blotting	NULL
.	NULL

The	NULL
293	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
D10	NULL
and	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
microcentrifuge	NULL
tube	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
[	NULL
50	NULL
mM	NULL
Tris-HC	NULL
]	NULL
,	NULL
pH	NULL
7.4/150	NULL
mM	NULL
NaCl/2	NULL
mM	NULL
EDTA/O.5	NULL
%	NULL
Nonidet	NULL
P-40/3	NULL
%	NULL
glycerol/1	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
/leupeptin	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
/aprotinin	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
]	NULL
.	NULL

Lysates	NULL
were	NULL
precleared	NULL
with	NULL
CL-6B	NULL
Sepharose	NULL
for	NULL
1	NULL
h	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
beads	NULL
(	NULL
Kodak	NULL
)	NULL
for	NULL
1-2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
M2	NULL
beads	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blotting	NULL
and	NULL
for	NULL
kinase	NULL
assays	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
were	NULL
transferred	NULL
to	NULL
0.45-um	NULL
(	NULL
pore	NULL
size	NULL
)	NULL
nitrocellulose	NULL
sheets	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

FLAG-tagged	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
MS	NULL
mouse	NULL
mAB	NULL
(	NULL
Eastman	NULL
Kodak	NULL
)	NULL
;	NULL
non-FLAG	NULL
tagged	NULL
LMP1	NULL
was	NULL
detected	NULL
with	NULL
mouse	NULL
$	NULL
12	NULL
anti-LMP	NULL
6	NULL
)	NULL
.	NULL

(	NULL
)	NULL
In	NULL
Vitro	NULL
Kinase	NULL
Assays	NULL
.	NULL

The	NULL
kinase	NULL
reactions	NULL
were	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
kinase	NULL
assay	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.5/5	NULL
mM	NULL
MgCl	NULL
;	NULL
/5	NULL
mM	NULL
NaF/2	NULL
mM	NULL
ATP	NULL
)	NULL
containing	NULL
in	NULL
vitro-translated	NULL
35S-labeled	NULL
IxBa	NULL
that	NULL
was	NULL
synthesized	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
TNT	NULL
,	NULL
Promega	NULL
)	NULL
.	NULL

Unlabeled	NULL
ATP	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
and	NULL
[	NULL
y-	NULL
>	NULL
2P	NULL
]	NULL
JATP	NULL
(	NULL
25	NULL
wCi	NULL
)	NULL
were	NULL
included	NULL
in	NULL
the	NULL
kinase	NULL
reaction	NULL
with	NULL
IKKBA9	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
20	NULL
min	NULL
or	NULL
1	NULL
h	NULL
at	NULL
30°C	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
adding	NULL
2X	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
boiling	NULL
,	NULL
followed	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
Western	NULL
blotting	NULL
,	NULL
and	NULL
autoradiography	NULL
.	NULL

For	NULL
immunoprecipitated	NULL
proteins	NULL
,	NULL
the	NULL
M2	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
once	NULL
with	NULL
kinase	NULL
wash	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.5/5	NULL
mM	NULL
MgCl	NULL
;	NULL
/5	NULL
mM	NULL
NaF	NULL
)	NULL
before	NULL
incubation	NULL
in	NULL
the	NULL
kinase	NULL
reaction	NULL
buffer	NULL
.	NULL

RESULTS	NULL
A	NULL
Dominant-Negative	NULL
NIK	NULL
Mutant	NULL
Inhibits	NULL
LMP1-Induced	NULL
NF-xB	NULL
Activation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NIK	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
kinase-site	NULL
mutant	NULL
NIK	NULL
(	NULL
NIK	NULL
KK429-430AA	NULL
)	NULL
on	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Activation	NULL
was	NULL
measured	NULL
through	NULL
effects	NULL
on	NULL
a	NULL
cotransfected	NULL
luciferase	NULL
reporter	NULL
with	NULL
three	NULL
upstream	NULL
NF-KB	NULL
sites	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
,	NULL
LMP1	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
CTAR2	NULL
(	NULL
LMPC-TAR1	NULL
)	NULL
induced	NULL
~25	NULL
%	NULL
of	NULL
the	NULL
total	NULL
LMP1	NULL
effect	NULL
,	NULL
whereas	NULL
10108	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Sylla	NULL
et	NULL
al	NULL
.	NULL

A	NULL
120	NULL
120	NULL
120	NULL
100	NULL
100	NULL
100	NULL
&	NULL
e	NULL
al	NULL
N	NULL
E	NULL
®	NULL
£	NULL
g	NULL
:	NULL
20	NULL
20	NULL
20	NULL
0	NULL
o	NULL
a	NULL
LMP1	NULL
+0	NULL
+	NULL
F-LMPCTAR1	NULL
£	NULL
%	NULL
F-LMPCTAR2	NULL
5	NULL
;	NULL
INIK	NULL
+	NULL
+	NULL
+	NULL
B	NULL
C	NULL
F-LMPCTAR1T	NULL
.	NULL

+	NULL
+	NULL
.	NULL

.	NULL

F-LMPCTAR2	NULL
.-	NULL
.	NULL

.	NULL

+	NULL
+	NULL
LMP1	NULL
-	NULL
+0	NULL
+	NULL
INIK	NULL
-+	NULL
a	NULL
INIK	NULL
_	NULL
-	NULL
£0	NULL
#	NULL
0	NULL
}	NULL
+	NULL
#	NULL
LMP1	NULL
[	NULL
>	NULL
<	NULL
~-	NULL
ELMPCTAR	NULL
!	NULL

I	NULL
i	NULL
,	NULL
F-LMPCTAR2	NULL
-	NULL
&	NULL
*	NULL
*	NULL
*	NULL
10	NULL
2	NULL
30	NULL
4	NULL
os	NULL
ANTI-LMP1	NULL
ANTI-FLAG	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Dominant	NULL
negative	NULL
mutant	NULL
of	NULL
protein	NULL
kinase	NULL
NIK	NULL
(	NULL
NI-KKK429-430AA	NULL
)	NULL
inhibits	NULL
NF-KB	NULL
activation	NULL
by	NULL
LMP1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
A	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
with	NULL
three	NULL
upstream	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
was	NULL
electroporated	NULL
into	NULL
293	NULL
cells	NULL
with	NULL
a	NULL
control	NULL
B-galactosidase	NULL
expression	NULL
construct	NULL
(	NULL
GKfgal	NULL
)	NULL
,	NULL
and	NULL
pCDNA3	NULL
(	NULL
Invitrogen	NULL
)	NULL
-based	NULL
expression	NULL
plasmids	NULL
for	NULL
LMP1	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
,	NULL
F-LMPCTAR1	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
,	NULL
or	NULL
F-LMPCTAR2	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
pCDNA3NIK	NULL
KK429-430AA	NULL
(	NULL
referred	NULL
as	NULL
INIK	NULL
)	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
cotransfected	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Values	NULL
of	NULL
NF-KB	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NIKKK429-430AA	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
corresponding	NULL
activities	NULL
(	NULL
set	NULL
at	NULL
100	NULL
%	NULL
)	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
NIKKK429-430AA	NULL
.	NULL

Mean	NULL
values	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
relative	NULL
luciferase	NULL
activities	NULL
from	NULL
four	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

In	NULL
these	NULL
four	NULL
experiments	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
full-length	NULL
LMP1	NULL
was	NULL
an	NULL
average	NULL
of	NULL
29-fold	NULL
,	NULL
whereas	NULL
LMPCTAR1	NULL
induced	NULL
I9-fold	NULL
and	NULL
LMPCTAR2	NULL
induced	NULL
19-fold	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
LMP1	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
NIKKK429-430AA	NULL
(	NULL
INIK	NULL
)	NULL
.	NULL

LMP1	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
S12	NULL
monoclonal	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
F-LMPCTAR1	NULL
and	NULL
F-LMPCTAR2	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
NIKKK429-430AA	NULL
(	NULL
INIK	NULL
)	NULL
.	NULL

FLAG-tagged	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
MS	NULL
monoclonal	NULL
anti-FLAG	NULL
antibody	NULL
.	NULL

LMP1	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
CTAR1	NULL
(	NULL
LMPCTAR2	NULL
)	NULL
induced	NULL
about	NULL
75	NULL
%	NULL
of	NULL
the	NULL
LMP1	NULL
effect	NULL
.	NULL

The	NULL
dominant	NULL
negative	NULL
NIK	NULL
inhibited	NULL
50	NULL
%	NULL
or	NULL
more	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-activation	NULL
that	NULL
was	NULL
induced	NULL
by	NULL
full-length	NULL
LMP1	NULL
,	NULL
by	NULL
LMPCTAR1	NULL
,	NULL
or	NULL
by	NULL
LMPCTAR2	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
activation	NULL
by	NULL
dominant	NULL
negative	NULL
NIK	NULL
was	NULL
not	NULL
due	NULL
to	NULL
an	NULL
effect	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
NIK	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
various	NULL
LMP1	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NIK	NULL
can	NULL
substantially	NULL
affect	NULL
or	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
LMP1	NULL
,	NULL
LMPCTAR1	NULL
,	NULL
and	NULL
CTAR2	NULL
.	NULL

NIK	NULL
Induces	NULL
IxBa	NULL
Phosphorylation	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
in	NULL
Rabbit	NULL
Reticulocyte	NULL
Lysates	NULL
.	NULL

NIK	NULL
activation	NULL
by	NULL
TNF	NULL
treatment	NULL
or	NULL
overexpression	NULL
leads	NULL
to	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
NIK	NULL
KK429-430AA	NULL
blocks	NULL
TNF-	NULL
or	NULL
interleukin	NULL
1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
can	NULL
signal	NULL
its	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
after	NULL
TNF	NULL
treatment	NULL
(	NULL
29	NULL
)	NULL
.	NULL

We	NULL
sought	NULL
to	NULL
further	NULL
analyze	NULL
the	NULL
role	NULL
of	NULL
NIK	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
evaluating	NULL
whether	NULL
NIK	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
,	NULL
in	NULL
vitro	NULL
.	NULL

Wild-type	NULL
and	NULL
Ser	NULL
-	NULL
>	NULL
Ala	NULL
mutated	NULL
forms	NULL
of	NULL
IxBa	NULL
were	NULL
incubated	NULL
under	NULL
standard	NULL
kinase	NULL
reaction	NULL
conditions	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
absence	NULL
of	NULL
NIK	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

NIK	NULL
was	NULL
able	NULL
to	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
++	NULL
~	NULL
c	NULL
t	NULL
t	NULL
t	NULL
IxBa	NULL
S32/36A	NULL
IxBaS32A	NULL
IxBaS36A	NULL
NIK	NULL
PlxBa	NULL
IKBQLi	NULL
mee	NULL
``	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

NIK	NULL
induces	NULL
IxBa	NULL
phosphorylation	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
.	NULL

In	NULL
vitro-translated	NULL
*°S-labeled	NULL
NIK	NULL
and	NULL
*S-labeled	NULL
wild-type	NULL
IxBa	NULL
,	NULL
$	NULL
32/36A	NULL
,	NULL
S32A	NULL
,	NULL
or	NULL
S36A	NULL
mutants	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
standard	NULL
kinase	NULL
buffer	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
IxBa	NULL
,	NULL
and	NULL
phosphorylated	NULL
IxBa	NULL
(	NULL
PIxBa	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

c	NULL
#	NULL
4	NULL
a	NULL
a	NULL
a	NULL
00	NULL
a	NULL
+	NULL
+0	NULL
6	NULL
oa	NULL
+	NULL
000	NULL
4+	NULL
a	NULL
-+	NULL
a	NULL
4+	NULL
_	NULL
£004	NULL
a	NULL
a	NULL
+o	NULL
#	NULL
a	NULL
a	NULL
induce	NULL
phosphorylation	NULL
of	NULL
wild-type	NULL
IxBa	NULL
,	NULL
IxBaS32A	NULL
,	NULL
and	NULL
IxBaS36A	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
retarded	NULL
mobility	NULL
and	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
mobility	NULL
of	NULL
IxBaS32/36A	NULL
(	NULL
mutated	NULL
at	NULL
both	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NIK-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
as	NULL
judged	NULL
by	NULL
gel	NULL
retardation	NULL
)	NULL
is	NULL
dependent	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NIK	NULL
phosphorylates	NULL
I	NULL
«	NULL
xBa	NULL
directly	NULL
or	NULL
requires	NULL
other	NULL
cellular	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
from	NULL
the	NULL
reticulocyte	NULL
lysate	NULL
,	NULL
FLAG-tagged	NULL
NIK	NULL
(	NULL
F-NIK	NULL
)	NULL
and	NULL
IxBa	NULL
were	NULL
purified	NULL
by	NULL
immunoprecipitation	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
standard	NULL
kinase	NULL
reac-tion	NULL
.	NULL

Incubation	NULL
of	NULL
in	NULL
vifro-translated	NULL
F-NIK	NULL
with	NULL
in	NULL
vitro-translated	NULL
IxBa	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
resulted	NULL
in	NULL
IxBa	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
vitro-translated	NULL
F-NIK	NULL
could	NULL
also	NULL
phosphorylate	NULL
immune	NULL
affinity-purified	NULL
in	NULL
vitro-translated	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
immune	NULL
affinity-purified	NULL
F-NIK	NULL
was	NULL
unable	NULL
to	NULL
phosphorylate	NULL
immune	NULL
affinity-purified	NULL
IxBa	NULL
,	NULL
even	NULL
when	NULL
the	NULL
affinity-purified	NULL
F-NIK	NULL
was	NULL
preincubated	NULL
with	NULL
reticulocyte	NULL
lysate	NULL
to	NULL
restore	NULL
it	NULL
to	NULL
an	NULL
active	NULL
phosphorylated	NULL
state	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
4	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Only	NULL
when	NULL
the	NULL
immune	NULL
affinity-purified	NULL
,	NULL
preincu-bated	NULL
,	NULL
and	NULL
phosphorylated	NULL
F-NIK	NULL
was	NULL
added	NULL
to	NULL
in	NULL
vitro-translated	NULL
IxBa	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
was	NULL
IxBa	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
phosphorylated	NULL
NIK	NULL
requires	NULL
additional	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
from	NULL
the	NULL
reticulocyte	NULL
lysate	NULL
for	NULL
IxBa	NULL
phosphorylation	NULL
.	NULL

Dominant	NULL
Negative	NULL
IKKa	NULL
«	NULL
or	NULL
IKK	NULL
Inhibit	NULL
LMP1-Induced	NULL
NF-xB	NULL
Activation	NULL
.	NULL

While	NULL
these	NULL
studies	NULL
were	NULL
in	NULL
progress	NULL
,	NULL
IKKa	NULL
IkBa	NULL
++	NULL
+	NULL
-	NULL
_-F-NIK	NULL
_-	NULL
+	NULL
=	NULL
_-IPlkBa	NULL
-	NULL
=-	NULL
=-	NULL
_+	NULL
IPF-NIK	NULL
_-	NULL
_	NULL
=-	NULL
O+	NULL
+	NULL
#	NULL
_	NULL
+	NULL
+	NULL
Waite	NULL
,	NULL
PlkBa	NULL
«	NULL
a	NULL
»	NULL
WBt	NULL
HB	NULL
ase	NULL
aum	NULL
4	NULL
--	NULL
IKBo	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

NIK	NULL
phosphorylates	NULL
IxBa	NULL
in	NULL
the	NULL
presence	NULL
but	NULL
not	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

In	NULL
vifro-translated	NULL
*5S-labeled	NULL
F-NIK	NULL
and	NULL
I	NULL
«	NULL
Ba	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
or	NULL
,	NULL
after	NULL
immunoprecipitation	NULL
from	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
IPIkBa	NULL
+	NULL
IPF-NIK	NULL
)	NULL
,	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
standard	NULL
kinase	NULL
buffer	NULL
containing	NULL
2.5	NULL
wM	NULL
okadaic	NULL
acid	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Sylla	NULL
et	NULL
al	NULL
.	NULL

was	NULL
identified	NULL
as	NULL
a	NULL
NIK	NULL
-interacting	NULL
kinase	NULL
and	NULL
as	NULL
part	NULL
of	NULL
an	NULL
IxB	NULL
kinase	NULL
complex	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
23	NULL
,	NULL
25	NULL
)	NULL
.	NULL

IKKS	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
homologue	NULL
of	NULL
IKKa	NULL
and	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
complex	NULL
that	NULL
phosphorylates	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TNF-a	NULL
(	NULL
24	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
IKKa	NULL
and	NULL
IKK	NULL
in	NULL
LMP1-induced	NULL
NF-kB	NULL
activation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
dominant	NULL
negative	NULL
IKKa	NULL
or	NULL
IKK	NULL
on	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
dominant	NULL
negative	NULL
IKKa	NULL
(	NULL
IKKaK44A	NULL
)	NULL
that	NULL
inhibited	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
23	NULL
,	NULL
25	NULL
)	NULL
also	NULL
inhibited	NULL
LMP1-	NULL
,	NULL
LMPCTAR1-	NULL
,	NULL
and	NULL
LMPCTAR2-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
was	NULL
dose-dependent	NULL
and	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
IKKaKA44A	NULL
on	NULL
LMP1	NULL
expression	NULL
because	NULL
the	NULL
levels	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
LMP1	NULL
proteins	NULL
were	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
IKKaK44A	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
for	NULL
LMPCTAR1	NULL
and	NULL
LMPCTAR2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IKKa	NULL
affects	NULL
or	NULL
mediates	NULL
LMP1-	NULL
,	NULL
LMPCTAR1-	NULL
,	NULL
or	NULL
LMPCTAR2-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
IKK	NULL
in	NULL
LMP1-induced	NULL
NF-kB	NULL
activation	NULL
,	NULL
two	NULL
IKKB	NULL
cDNA	NULL
clones	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
B	NULL
cell	NULL
cDNA	NULL
library	NULL
.	NULL

One	NULL
cDNA	NULL
,	NULL
IKKBA9	NULL
,	NULL
is	NULL
missing	NULL
nine	NULL
N-terminal	NULL
codons	NULL
and	NULL
activated	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
15-fold	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
full-length	NULL
IKK	NULL
(	NULL
23	NULL
)	NULL
.	NULL

A	NULL
second	NULL
cDNA	NULL
,	NULL
IKKBA34	NULL
,	NULL
is	NULL
missing	NULL
34	NULL
N-terminal	NULL
residues	NULL
,	NULL
including	NULL
the	NULL
ATP-binding	NULL
site	NULL
.	NULL

IKKBA34	NULL
did	NULL
not	NULL
activate	NULL
NF-kB	NULL
and	NULL
inhibited	NULL
TNF-induced	NULL
activation	NULL
of	NULL
A	NULL
120	NULL
100	NULL
&	NULL
e	NULL
]	NULL
&	NULL
0	NULL
®	NULL
[	NULL
e	NULL
]	NULL
Percent	NULL
luciferase	NULL
activity	NULL
N	NULL
o	NULL
el	NULL
FLMP1	NULL
4004+	NULL
+o	NULL
+	NULL
FALMPCTAR1	NULL
hock	NULL
+0	NULL
oo	NULL
F-LMPCTARZ	NULL
+	NULL
M-IKKoK44A	NULL
O	NULL
[	NULL
1	NULL
.5	NULL
1	NULL
0	NULL
.5	NULL
1	NULL
2	NULL
O	NULL
.1	NULL
6	NULL
C	NULL
120	NULL
oa	NULL
0	NULL
©	NULL
60	NULL
40	NULL
20	NULL
Percent	NULL
luciferase	NULL
activity	NULL
0	NULL
F-LMP1	NULL
+	NULL
+	NULL
++	NULL
F-LMPCTAR1	NULL
$	NULL
o	NULL
p	NULL
w	NULL
ow	NULL
F-LMPCTAR2	NULL
+o	NULL
to	NULL
o4	NULL
F-IKKBA3M	NULL
o	NULL
a	NULL
.5	NULL
1	NULL
0	NULL
Us	NULL
10	NULL
2	NULL
0	NULL
10.5	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
10109	NULL
NF-B	NULL
in	NULL
transfected	NULL
293	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IKKBA34	NULL
also	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
full-length	NULL
LMP1	NULL
by	NULL
80	NULL
%	NULL
,	NULL
by	NULL
LMPCTAR1	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
,	NULL
and	NULL
by	NULL
LMPCTAR2	NULL
by	NULL
70	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
inhibitions	NULL
were	NULL
dose-dependent	NULL
and	NULL
did	NULL
not	NULL
reach	NULL
saturation	NULL
at	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
transfected	NULL
DNA	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
more	NULL
modest	NULL
effect	NULL
of	NULL
IKKBA34	NULL
on	NULL
LMPCTAR1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
a	NULL
substantive	NULL
difference	NULL
in	NULL
the	NULL
role	NULL
of	NULL
IKK	NULL
in	NULL
LMPCTAR1	NULL
versus	NULL
LMPCTAR2	NULL
downstream	NULL
pathways	NULL
and	NULL
is	NULL
more	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
higher	NULL
level	NULL
of	NULL
LMPCTAR1	NULL
expression	NULL
compared	NULL
with	NULL
LMPCTAR2	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
data	NULL
for	NULL
each	NULL
experiment	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
smaller	NULL
amounts	NULL
of	NULL
LMPCTAR1	NULL
expression	NULL
vector	NULL
was	NULL
80	NULL
%	NULL
inhibited	NULL
by	NULL
IKKBA34	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
IKKB	NULL
also	NULL
affects	NULL
or	NULL
mediates	NULL
LMP1	NULL
,	NULL
LMPCTAR1	NULL
,	NULL
and	NULL
LMPCTARZ	NULL
induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

Overexpression	NULL
of	NULL
wild-type	NULL
IKKa	NULL
or	NULL
IKKB	NULL
potentiates	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
is	NULL
consistent	NULL
with	NULL
their	NULL
role	NULL
in	NULL
mediating	NULL
TNF-induced	NULL
NF-kB	NULL
activation	NULL
(	NULL
23-27	NULL
)	NULL
.	NULL

Although	NULL
overexpression	NULL
of	NULL
IKKa	NULL
or	NULL
IKK	NULL
B	NULL
in	NULL
293	NULL
cells	NULL
resulted	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
high-level	NULL
IKKa	NULL
or	NULL
IKK	NULL
coexpression	NULL
with	NULL
LMP1	NULL
resulted	NULL
in	NULL
less	NULL
NF-KB	NULL
activation	NULL
than	NULL
was	NULL
induced	NULL
by	NULL
LMP1	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
lower-level	NULL
expression	NULL
of	NULL
IKKa	NULL
and/or	NULL
IKK	NULL
B	NULL
had	NULL
neither	NULL
an	NULL
enhancing	NULL
nor	NULL
an	NULL
inhibiting	NULL
effect	NULL
on	NULL
LMP1	NULL
B	NULL
M-IKKaK44	NULL
A	NULL
(	NULL
ug	NULL
)	NULL
O	NULL
O01	NULL
0.5	NULL
1.0	NULL
F-LMP1	NULL
(	NULL
ug	NULL
)	NULL
4.0	NULL
4.0	NULL
4.0	NULL
4.0	NULL
M-	NULL
!	NULL

Kkok44	NULL
a	NULL
>	NULL
``	NULL
s	NULL
F-LMP	NULL
1	NULL
-J	NULL
>	NULL
AM	NULL
,	NULL
wom	NULL
,	NULL
»	NULL
A	NULL
,	NULL
settin	NULL
«	NULL
mme	NULL
<	NULL
mmmw	NULL
>	NULL
«	NULL
iits	NULL
~Lee	NULL
¢	NULL
1	NULL
2	NULL
3	NULL
4	NULL
D	NULL
F-IKKBA34	NULL
(	NULL
ug	NULL
)	NULL
0	NULL
__	NULL
01	NULL
F-LMP1	NULL
(	NULL
ug	NULL
)	NULL
4.0	NULL
4.0	NULL
F-IKKBA34	NULL
#	NULL
>	NULL
___	NULL
.	NULL

FLMP1b-h	NULL
«	NULL
mmm	NULL
o	NULL
4.0	NULL
0.5	NULL
4.0	NULL
«	NULL
mens	NULL
*	NULL
>	NULL
3	NULL
1	NULL
2	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
IKKa	NULL
(	NULL
M-IKKaK44A	NULL
)	NULL
(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
or	NULL
IKK	NULL
(	NULL
F-IKKBA34	NULL
)	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
on	NULL
LMP1-	NULL
,	NULL
LMPCTAR1-	NULL
,	NULL
or	NULL
LMPCTAR2-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

F-LMP1	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
in	NULL
pSGS5	NULL
,	NULL
F-LMPCTAR1	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
,	NULL
or	NULL
F-LMPCTARZ	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
in	NULL
pCDNA3	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
3XxB	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmid	NULL
,	NULL
a	NULL
B-galactosidase	NULL
expression	NULL
construct	NULL
,	NULL
and	NULL
increasing	NULL
amounts	NULL
(	NULL
0.1-2	NULL
ug	NULL
)	NULL
of	NULL
pRKS5-myc-IKKaK44A	NULL
,	NULL
pCDN3-F-IKKBA34	NULL
,	NULL
or	NULL
pCDNA3	NULL
,	NULL
a	NULL
vector	NULL
control	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
high	NULL
expression	NULL
of	NULL
F-LMPCTAR1	NULL
relative	NULL
to	NULL
F-LMP1	NULL
and	NULL
LMPCTAR2	NULL
,	NULL
0.5-2	NULL
ug	NULL
of	NULL
myc-IKKaK44A	NULL
and	NULL
IKKBA34	NULL
were	NULL
cotransfected	NULL
with	NULL
LMPCTAR1	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
LMP1	NULL
constructs	NULL
cotransfected	NULL
with	NULL
IKKaK44A	NULL
or	NULL
IKKBA34	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
activities	NULL
(	NULL
set	NULL
at	NULL
100	NULL
%	NULL
)	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IKKaK44A	NULL
or	NULL
IKKBA34	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
averaged	NULL
76-fold	NULL
,	NULL
whereas	NULL
LMPCTAR1-induced	NULL
activation	NULL
averaged	NULL
17-fold	NULL
and	NULL
LMPCTAR2-induced	NULL
activation	NULL
averaged	NULL
53-fold	NULL
.	NULL

Representative	NULL
relative	NULL
luciferase	NULL
activities	NULL
from	NULL
at	NULL
least	NULL
two	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
F-LMP1	NULL
,	NULL
myc-IKKaK44A	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
F-IKKBA34	NULL
(	NULL
1	NULL
)	NULL
expression	NULL
levels	NULL
.	NULL

After	NULL
protein	NULL
transfer	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
sequentially	NULL
probed	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
detect	NULL
FLAG	NULL
(	NULL
MS	NULL
)	NULL
or	NULL
to	NULL
detect	NULL
M-IKKaK44A	NULL
(	NULL
9E10	NULL
)	NULL
.	NULL

10110	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Sylla	NULL
et	NULL
al	NULL
.	NULL

124	NULL
7	NULL
10	NULL
4	NULL
8	NULL
Percent	NULL
luciferase	NULL
activity	NULL
4	NULL
8	NULL
8	NULL
O	NULL
4	NULL
LMP1	NULL
+	NULL
+	NULL
+	NULL
+	NULL
M-IKKo	NULL
.	NULL

+	NULL
+	NULL
F-IKKBAY	NULL
+	NULL
4	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

IKKa	NULL
and	NULL
IKKBA9	NULL
inhibit	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Luciferase	NULL
reporter	NULL
assays	NULL
are	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
expression	NULL
pCDNA3-LMP1	NULL
,	NULL
pRK5-myc-IKKa	NULL
,	NULL
and	NULL
pCDNA3-F-IKKBA9	NULL
.	NULL

induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Despite	NULL
its	NULL
negative	NULL
effects	NULL
on	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
,	NULL
Flag-tagged	NULL
IKK	NULL
immunoprecipitated	NULL
from	NULL
293	NULL
cells	NULL
was	NULL
able	NULL
to	NULL
phosphorylate	NULL
IxBa	NULL
in	NULL
kinase	NULL
buffer	NULL
,	NULL
in	NULL
vitro	NULL
.	NULL

IKKB	NULL
immunoprecipitated	NULL
from	NULL
LMP1	NULL
expressing	NULL
cells	NULL
was	NULL
not	NULL
more	NULL
active	NULL
in	NULL
phosphorylating	NULL
I	NULL
«	NULL
xBa	NULL
in	NULL
vitro	NULL
than	NULL
IKK	NULL
B	NULL
from	NULL
LMP1-negative	NULL
293	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
IKKa	NULL
and	NULL
IKK	NULL
being	NULL
important	NULL
mediators	NULL
of	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
but	NULL
raise	NULL
questions	NULL
about	NULL
the	NULL
precise	NULL
stoichiometry	NULL
or	NULL
regulation	NULL
of	NULL
this	NULL
pathway	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

DISCUSSION	NULL
TNF	NULL
signaling	NULL
through	NULL
TNFRI	NULL
has	NULL
been	NULL
well	NULL
characterized	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
the	NULL
293	NULL
cells	NULL
that	NULL
we	NULL
used	NULL
(	NULL
22-27	NULL
,	NULL
29-37	NULL
)	NULL
.	NULL

In	NULL
such	NULL
cells	NULL
TNF	NULL
induces	NULL
trimerization	NULL
of	NULL
TNFRI	NULL
.	NULL

TNFRI	NULL
associates	NULL
with	NULL
TRADD	NULL
and	NULL
RIP	NULL
.	NULL

TRADD	NULL
and	NULL
RIP	NULL
associate	NULL
with	NULL
TRAF1	NULL
and	NULL
2	NULL
.	NULL

TRAF2	NULL
associates	NULL
and	NULL
probably	NULL
activates	NULL
NIK	NULL
.	NULL

NIK	NULL
activates	NULL
IKKa	NULL
and	NULL
IKK	NULL
.	NULL

IK	NULL
Ka	NULL
and	NULL
IKK	NULL
B	NULL
phosphorylate	NULL
IkBa	NULL
,	NULL
which	NULL
is	NULL
then	NULL
ubiquitinated	NULL
and	NULL
de-graded	NULL
,	NULL
releasing	NULL
active	NULL
NF-kB	NULL
.	NULL

Although	NULL
epithelial	NULL
cells	NULL
primarily	NULL
express	NULL
TNFRI	NULL
,	NULL
cells	NULL
of	NULL
bone	NULL
marrow	NULL
origin	NULL
primarily	NULL
express	NULL
TNFRII	NULL
.	NULL

TNF	NULL
also	NULL
induces	NULL
trimerization	NULL
of	NULL
TNFRII	NULL
and	NULL
the	NULL
downstream	NULL
pathways	NULL
appear	NULL
to	NULL
only	NULL
differ	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
trimerized	NULL
TNFRII	NULL
to	NULL
directly	NULL
engage	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
,	NULL
rather	NULL
than	NULL
indirectly	NULL
engaging	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
through	NULL
TRADD	NULL
and	NULL
RIP	NULL
(	NULL
22	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

For	NULL
both	NULL
TNFR	NULL
I	NULL
and	NULL
TNFRII	NULL
,	NULL
NIK	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
TRAF2	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Our	NULL
in	NULL
vitro	NULL
observations	NULL
that	NULL
NIK	NULL
indirectly	NULL
induces	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
are	NULL
consistent	NULL
with	NULL
and	NULL
extend	NULL
previous	NULL
data	NULL
showing	NULL
that	NULL
NIK	NULL
induces	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
activates	NULL
NF-KB	NULL
in	NULL
transfected	NULL
293	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
herein	NULL
indicate	NULL
that	NULL
the	NULL
EBV-transforming	NULL
protein	NULL
LMP1	NULL
induces	NULL
NF-KB	NULL
activation	NULL
through	NULL
a	NULL
NIK-	NULL
,	NULL
IKKa-	NULL
,	NULL
and	NULL
IKK	NULL
3-kinase-dependent	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Dominant	NULL
negative	NULL
forms	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKKB	NULL
blocked	NULL
LMP1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
without	NULL
affecting	NULL
LMP1	NULL
ex-pression	NULL
.	NULL

Because	NULL
NIK	NULL
and	NULL
the	NULL
IxBa	NULL
kinases	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
pathways	NULL
through	NULL
which	NULL
TNF	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
evidence	NULL
that	NULL
LMP1	NULL
signals	NULL
through	NULL
cellular	NULL
pathways	NULL
that	NULL
are	NULL
ordinarily	NULL
activated	NULL
by	NULL
TNF	NULL
and	NULL
other	NULL
TNF	NULL
family	NULL
ligands	NULL
.	NULL

LMP1	NULL
activates	NULL
NF-kB	NULL
from	NULL
CTAR1	NULL
by	NULL
associating	NULL
with	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
and	NULL
from	NULL
CTARZ	NULL
by	NULL
associating	NULL
with	NULL
TRADD	NULL
(	NULL
12-14	NULL
,	NULL
18	NULL
)	NULL
,	NULL
in	NULL
striking	NULL
parallel	NULL
to	NULL
both	NULL
TNFRII	NULL
and	NULL
TNFRI	NULL
pathways	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
previous	NULL
evidence	NULL
linking	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRADD	NULL
to	NULL
LMPCTAR1-	NULL
and	NULL
CTAR2	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
mediated	NULL
NF-KB	NULL
activation	NULL
,	NULL
we	NULL
anticipated	NULL
that	NULL
LMPCTAR1-and	NULL
CTAR2-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
would	NULL
be	NULL
inhibited	NULL
by	NULL
coexpression	NULL
of	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKK3	NULL
.	NULL

Indeed	NULL
,	NULL
NIK	NULL
KK429-430A¥	NULL
A	NULL
inhibited	NULL
LMP1-	NULL
,	NULL
LMPCTAR1-	NULL
,	NULL
or	NULL
LMPCTAR2-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
at	NULL
least	NULL
50	NULL
%	NULL
and	NULL
did	NULL
not	NULL
inhibit	NULL
LMPCTAR1	NULL
or	NULL
LMPCTAR2	NULL
expression	NULL
,	NULL
indicating	NULL
that	NULL
NIK	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
LMPCTAR1-	NULL
and	NULL
LMPCTAR2-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Because	NULL
activated	NULL
NIK	NULL
complexes	NULL
with	NULL
and	NULL
activates	NULL
IKKa	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
IKKB	NULL
(	NULL
23-27	NULL
,	NULL
36	NULL
,	NULL
37	NULL
)	NULL
,	NULL
which	NULL
then	NULL
phosphorylate	NULL
IxBa	NULL
,	NULL
expression	NULL
of	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
IKKa	NULL
or	NULL
IKKB	NULL
also	NULL
blocked	NULL
LMPCTAR1-	NULL
and	NULL
CTAR2-mediated	NULL
NF-kB	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
LMPCTAR1-induced	NULL
NF-KB	NULL
activation	NULL
was	NULL
somewhat	NULL
more	NULL
resistant	NULL
to	NULL
IKKBA34	NULL
blockage	NULL
than	NULL
was	NULL
LMPCTAR2-induced	NULL
NF-kB	NULL
activation	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
attributed	NULL
to	NULL
the	NULL
higher	NULL
level	NULL
of	NULL
LMPCTAR1	NULL
expression	NULL
versus	NULL
LMPCTAR2	NULL
.	NULL

Indeed	NULL
,	NULL
lower-level	NULL
expression	NULL
of	NULL
LMPCTAR1	NULL
resulted	NULL
in	NULL
substantial	NULL
blockage	NULL
by	NULL
IKKBA34	NULL
.	NULL

However	NULL
,	NULL
LMPCTAR1	NULL
was	NULL
also	NULL
less	NULL
inhibited	NULL
by	NULL
IKKBA34	NULL
than	NULL
it	NULL
was	NULL
by	NULL
IKKa	NULL
K44A	NULL
.	NULL

This	NULL
latter	NULL
effect	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
differential	NULL
low	NULL
expression	NULL
of	NULL
IKKBA34	NULL
versus	NULL
IKKa	NULL
K44A	NULL
or	NULL
to	NULL
a	NULL
larger	NULL
pool	NULL
size	NULL
of	NULL
wild-type	NULL
IKK	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
possibilities	NULL
,	NULL
IKKBA34	NULL
was	NULL
also	NULL
less	NULL
effective	NULL
than	NULL
IKKa	NULL
K44A	NULL
in	NULL
inhibiting	NULL
LMP1	NULL
and	NULL
LMPCTAR2	NULL
as	NULL
well	NULL
as	NULL
LMPCTAR1	NULL
.	NULL

Attempts	NULL
to	NULL
further	NULL
investigate	NULL
potential	NULL
differences	NULL
in	NULL
expression	NULL
levels	NULL
between	NULL
IKKBA34	NULL
and	NULL
IKKa	NULL
K44A	NULL
have	NULL
so	NULL
far	NULL
been	NULL
unrevealing	NULL
,	NULL
in	NULL
part	NULL
due	NULL
to	NULL
the	NULL
different	NULL
epitope	NULL
tags	NULL
.	NULL

The	NULL
similar	NULL
effects	NULL
of	NULL
dominant	NULL
negative	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKK	NULL
on	NULL
NF-KB	NULL
activation	NULL
mediated	NULL
by	NULL
LMPCTAR1	NULL
and	NULL
LMPCTAR2	NULL
are	NULL
altogether	NULL
most	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
fundamental	NULL
differences	NULL
between	NULL
the	NULL
effects	NULL
of	NULL
CTAR1/TES1	NULL
and	NULL
CTAR2/TES2	NULL
on	NULL
cell	NULL
growth	NULL
and	NULL
gene	NULL
activation	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
biochemical	NULL
interactions	NULL
upstream	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKK	NULL
activation	NULL
.	NULL

Given	NULL
the	NULL
similarity	NULL
of	NULL
LMP1	NULL
to	NULL
TNFRI	NULL
and	NULL
TNFRII	NULL
and	NULL
the	NULL
previous	NULL
finding	NULL
that	NULL
IKKa	NULL
or	NULL
IKK	NULL
overexpression	NULL
stimulated	NULL
TNF-mediated	NULL
NF-KB	NULL
activation	NULL
,	NULL
we	NULL
were	NULL
surprised	NULL
that	NULL
overexpression	NULL
of	NULL
wild-type	NULL
IKKa	NULL
or	NULL
IKK	NULL
inhibited	NULL
LMP1-induced	NULL
NF-KB	NULL
activation	NULL
and	NULL
that	NULL
LMP1	NULL
expression	NULL
did	NULL
not	NULL
potentiate	NULL
IKK-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
these	NULL
results	NULL
could	NULL
be	NULL
the	NULL
possibility	NULL
that	NULL
high-level	NULL
expression	NULL
of	NULL
these	NULL
kinases	NULL
may	NULL
alter	NULL
the	NULL
normal	NULL
stoichiometry	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
cascade	NULL
.	NULL

For	NULL
example	NULL
,	NULL
overexpression	NULL
of	NULL
IKKa	NULL
or	NULL
IKK	NULL
may	NULL
sequester	NULL
key	NULL
regulatory	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Alternatively	NULL
,	NULL
IKKa	NULL
and	NULL
IKK	NULL
B	NULL
may	NULL
already	NULL
be	NULL
in	NULL
relative	NULL
molar	NULL
excess	NULL
versus	NULL
IxBa	NULL
and	NULL
overexpression	NULL
simply	NULL
increases	NULL
interaction	NULL
with	NULL
other	NULL
targets	NULL
or	NULL
regulators	NULL
of	NULL
these	NULL
kinases	NULL
without	NULL
positively	NULL
affecting	NULL
the	NULL
efficiency	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
.	NULL

LMP1	NULL
may	NULL
differ	NULL
in	NULL
these	NULL
effects	NULL
from	NULL
TNFRs	NULL
because	NULL
of	NULL
their	NULL
association	NULL
with	NULL
other	NULL
putative	NULL
signaling	NULL
molecules	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
,	NULL
which	NULL
may	NULL
indirectly	NULL
affect	NULL
NF-KB	NULL
activation	NULL
.	NULL

The	NULL
summary	NULL
drawing	NULL
of	NULL
LMP1	NULL
induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
includes	NULL
several	NULL
areas	NULL
of	NULL
uncertainty	NULL
.	NULL

For	NULL
example	NULL
,	NULL
although	NULL
TRAFs	NULL
and	NULL
TRADD	NULL
are	NULL
constitutively	NULL
associated	NULL
with	NULL
LMP1	NULL
in	NULL
EBV	NULL
-transformed	NULL
B	NULL
lymphocytes	NULL
or	NULL
transfected	NULL
293	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
18	NULL
)	NULL
,	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKK	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
in	NULL
a	NULL
separate	NULL
neighboring	NULL
complex	NULL
.	NULL

By	NULL
immune	NULL
microscopy	NULL
,	NULL
TR	NULL
AFs	NULL
significantly	NULL
colocalize	NULL
to	NULL
LMP1	NULL
patches	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
12	NULL
,	NULL
18	NULL
)	NULL
,	NULL
whereas	NULL
IKKa	NULL
or	NULL
IKKB	NULL
are	NULL
much	NULL
less	NULL
LMP1-associated	NULL
and	NULL
are	NULL
evident	NULL
throughout	NULL
the	NULL
cytoplasm	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
although	NULL
TRAFs	NULL
or	NULL
TRADD	NULL
readily	NULL
coimmunoprecipitate	NULL
with	NULL
LMP1	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
18	NULL
)	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
coimmunoprecipitate	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKKG	NULL
with	NULL
LMP1	NULL
from	NULL
cells	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
LMP1	NULL
and	NULL
epitope-tagged	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
or	NULL
IKK	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
experiments	NULL
indicate	NULL
that	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKKS	NULL
are	NULL
effectors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
from	NULL
CTAR1/	NULL
TES1	NULL
and	NULL
CTAR2/TES2	NULL
and	NULL
confirm	NULL
the	NULL
functional	NULL
similarity	NULL
of	NULL
these	NULL
sites	NULL
to	NULL
the	NULL
TRAF	NULL
and	NULL
TRADD	NULL
binding	NULL
domains	NULL
of	NULL
Medical	NULL
Sciences	NULL
:	NULL
Sylla	NULL
et	NULL
al	NULL
.	NULL

TNFR	NULL
II	NULL
and	NULL
TNFRI	NULL
,	NULL
respectively	NULL
.	NULL

However	NULL
,	NULL
although	NULL
LMPC-TAR2/TES2	NULL
associates	NULL
with	NULL
TRADD	NULL
and	NULL
propagates	NULL
robust	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
presumably	NULL
through	NULL
the	NULL
recruitment	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF	NULL
to	NULL
the	NULL
TRADD	NULL
N	NULL
terminus	NULL
,	NULL
LMPC-TAR2/TES2	NULL
interacts	NULL
with	NULL
only	NULL
a	NULL
part	NULL
of	NULL
the	NULL
TRADD	NULL
death	NULL
domain	NULL
and	NULL
does	NULL
not	NULL
propagate	NULL
a	NULL
discernable	NULL
proapoptotic	NULL
signal	NULL
through	NULL
TRADD	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LMP1	NULL
differs	NULL
partially	NULL
from	NULL
TNFRI	NULL
in	NULL
TRADD-mediated	NULL
signaling	NULL
.	NULL

We	NULL
thank	NULL
other	NULL
members	NULL
the	NULL
Kieff	NULL
laboratory	NULL
for	NULL
their	NULL
helpful	NULL
advice	NULL
and	NULL
comments	NULL
,	NULL
K.	NULL
Lee	NULL
and	NULL
M.	NULL
Barkett	NULL
for	NULL
IxBa	NULL
expression	NULL
plasmids	NULL
,	NULL
Drs	NULL
.	NULL

M.	NULL
Rothe	NULL
and	NULL
D.	NULL
Goeddel	NULL
for	NULL
IKKa	NULL
expression	NULL
plasmids	NULL
,	NULL
and	NULL
Dr.	NULL
W.	NULL
Miller	NULL
for	NULL
LMP1	NULL
expression	NULL
plasmids	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
CA47006	NULL
(	NULL
to	NULL
E.K	NULL
.	NULL
)	NULL

and	NULL
CA71705	NULL
(	NULL
to	NULL
G.M	NULL
.	NULL
)	NULL

and	NULL
by	NULL
the	NULL
Council	NULL
for	NULL
Tobacco	NULL
Research	NULL
(	NULL
to	NULL
T.D.G	NULL
.	NULL
)	NULL

.	NULL

B.S.S	NULL
.	NULL

is	NULL
a	NULL
visiting	NULL
fellow	NULL
from	NULL
the	NULL
International	NULL
Agency	NULL
for	NULL
Research	NULL
on	NULL
Cancer	NULL
,	NULL
Lyon	NULL
,	NULL
France	NULL
.	NULL

1	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
9150-9154	NULL
.	NULL

2	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
in	NULL
Fields	NULL
Virology	NULL
,	NULL
eds	NULL
.	NULL

Fields	NULL
,	NULL
B.	NULL
N.	NULL
,	NULL
Knipe	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
Lippincott-Raven	NULL
,	NULL
Philadelphia	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

2343-2396	NULL
.	NULL

3	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
,	NULL
Hu	NULL
,	NULL
H.	NULL
,	NULL
Opipari	NULL
,	NULL
A.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
&	NULL
Dixit	NULL
,	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24157-24160	NULL
.	NULL

4	NULL
.	NULL

Mitchell	NULL
,	NULL
T.	NULL
&	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
2968-2976	NULL
.	NULL

5	NULL
.	NULL

Huen	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Henderson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Croom	NULL
,	NULL
C.	NULL
D.	NULL
&	NULL
Rowe	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
549-3560	NULL
.	NULL

6	NULL
.	NULL

Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Raab-Traub	NULL
,	NULL
N.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
&	NULL
Mosialos	NULL
,	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
1116-1121	NULL
.	NULL

7	NULL
.	NULL

Kieser	NULL
,	NULL
A.	NULL
,	NULL
Kilger	NULL
,	NULL
E.	NULL
,	NULL
Gries	NULL
,	NULL
O.	NULL
,	NULL
Ueffing	NULL
,	NULL
M.	NULL
,	NULL
Kolch	NULL
,	NULL
W.	NULL
&	NULL
Hammerschmidt	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
6478-6485	NULL
.	NULL

8	NULL
.	NULL

Eliopoulos	NULL
,	NULL
A.	NULL
G.	NULL
&	NULL
Young	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
16	NULL
,	NULL
1731-1742	NULL
.	NULL

9	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
Licbowitz	NULL
,	NULL
D.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
43	NULL
,	NULL
831-840	NULL
.	NULL

10	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
Licbowitz	NULL
,	NULL
D.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
2337-2346	NULL
.	NULL

11	NULL
.	NULL

Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
&	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
67-74	NULL
.	NULL

12	NULL
.	NULL

-	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
VanArsdale	NULL
,	NULL
T.	NULL
,	NULL
Ware	NULL
,	NULL
C.	NULL
&	NULL
Kicff	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
389-399	NULL
.	NULL

13	NULL
.	NULL

Devergne	NULL
,	NULL
O.	NULL
,	NULL
Hatzivassilliou	NULL
,	NULL
E.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kleijnen	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
D.	NULL
&	NULL
Mosialos	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
7098-7108	NULL
.	NULL

14	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
12592-12597	NULL
.	NULL

15	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
,	NULL
Kaye	NULL
,	NULL
K.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
4369-4376	NULL
.	NULL

16	NULL
.	NULL

-	NULL
Licbowitz	NULL
,	NULL
D.	NULL
,	NULL
Mannick	NULL
,	NULL
J.	NULL
,	NULL
Takada	NULL
,	NULL
K.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
4612-4616	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
10111	NULL
Kaye	NULL
,	NULL
K.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
675-683	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Harada	NULL
,	NULL
J.	NULL
,	NULL
Devergne	NULL
,	NULL
O.	NULL
,	NULL
Isumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
D.	NULL
&	NULL
Mosialos	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
11085-11090	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kaye	NULL
,	NULL
K.	NULL
M.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
1447-1452	NULL
.	NULL

Flocttman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Rowe	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Oncogene	NULL
15	NULL
,	NULL
1851-1858	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
,	NULL
Tuomanen	NULL
,	NULL
E.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
321-330	NULL
.	NULL

Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
Boldin	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Kovalenko	NULL
,	NULL
A.	NULL
V.	NULL
&	NULL
Wallach	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
385	NULL
,	NULL
540-544	NULL
.	NULL

Regnier	NULL
,	NULL
C.	NULL
,	NULL
Song	NULL
,	NULL
H.	NULL
,	NULL
Gao	NULL
,	NULL
X.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
,	NULL
Cao	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Rothe	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
90	NULL
,	NULL
373-383	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Gao	NULL
,	NULL
X.	NULL
,	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
866-869	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hayakawa	NULL
,	NULL
M.	NULL
,	NULL
Rothwarf	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Zandi	NULL
,	NULL
E.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
388	NULL
,	NULL
548-554	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
Zhu	NULL
,	NULL
H.	NULL
,	NULL
Murray	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Shevchenko	NULL
,	NULL
A.	NULL
,	NULL
Bennett	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Young	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Barbosa	NULL
,	NULL
M.	NULL
&	NULL
Mann	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
860-886	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
Rothwarf	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Delhase	NULL
,	NULL
M.	NULL
,	NULL
Hayakawa	NULL
,	NULL
M.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
91	NULL
,	NULL
243-252	NULL
.	NULL

Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
D.	NULL
&	NULL
Rabb-Traub	NULL
,	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
586-594	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
Parent	NULL
,	NULL
L.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
853-862	NULL
.	NULL

Stancovski	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
91	NULL
,	NULL
299-302	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
4304-4307	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
Xiong	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
495-504	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
Huang	NULL
,	NULL
J.	NULL
,	NULL
Shu	NULL
,	NULL
H.	NULL
,	NULL
Baichwall	NULL
,	NULL
V.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
387-396	NULL
.	NULL

Ting	NULL
,	NULL
A.	NULL
,	NULL
Pimentel-Muinos	NULL
,	NULL
F.	NULL
&	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
6189-6196	NULL
.	NULL

Kelliher	NULL
,	NULL
M.	NULL
,	NULL
Grimm	NULL
,	NULL
S.	NULL
,	NULL
Ishida	NULL
,	NULL
Y.	NULL
,	NULL
Kuo	NULL
,	NULL
F.	NULL
,	NULL
Stanger	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
Immunity	NULL
8	NULL
,	NULL
297-303	NULL
.	NULL

Ling	NULL
,	NULL
L.	NULL
,	NULL
Cao	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
3792-3797	NULL
.	NULL

Nakano	NULL
,	NULL
H.	NULL
,	NULL
Shindo	NULL
,	NULL
M.	NULL
,	NULL
Sakon	NULL
,	NULL
S.	NULL
,	NULL
Nishinaka	NULL
,	NULL
S.	NULL
,	NULL
Mihara	NULL
,	NULL
M.	NULL
,	NULL
Yagita	NULL
,	NULL
H.	NULL
&	NULL
Okumura	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
3537-3542	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
Wong	NULL
,	NULL
W.	NULL
,	NULL
Henzel	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
681-692	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
Sarma	NULL
,	NULL
V.	NULL
,	NULL
Dixit	NULL
,	NULL
V.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
1424-1427	NULL
.	NULL

Song	NULL
,	NULL
H.	NULL
,	NULL
Dunbar	NULL
,	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Guo	NULL
,	NULL
D.	NULL
&	NULL
Donner	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
3574-3581	NULL
.	NULL

Schievella	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Graham	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Lin	NULL
,	NULL
L.	NULL
,	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
12069-12076	NULL
.	NULL

